TY - JOUR
T1 - Residual Kidney Function and Cause-Specific Mortality Among Incident Hemodialysis Patients
AU - Okazaki, Masaki
AU - Obi, Yoshitsugu
AU - Shafi, Tariq
AU - Rhee, Connie M.
AU - Kovesdy, Csaba P.
AU - Kalantar-Zadeh, Kamyar
N1 - © 2023 Published by Elsevier, Inc., on behalf of the International Society of Nephrology.
PY - 2023/10
Y1 - 2023/10
N2 - INTRODUCTION: The survival benefit of residual kidney function (RKF) in patients on hemodialysis is presumably due to enhanced fluid management and solute clearance. However, data are lacking on the association of renal urea clearance (CL
urea) with specific causes of death.
METHODS: We conducted a longitudinal cohort study of 39,623 adults initiating thrice-weekly in-center hemodialysis from 2007 to 2011 and had data on renal CL
urea and urine volume. Multivariable cause-specific proportional hazards model was used to examine the associations between baseline RKF and cause-specific mortality, including sudden cardiac death (SCD), non-SCD cardiovascular death (CVD), and non-CVD. Restricted cubic splines were fitted for change in RKF over 6 months after initiating hemodialysis.
RESULTS: Among 39,623 patients with data on baseline renal CL
urea and urine volume, there was a significant trend toward a higher mortality risk across lower RKF levels, irrespective of cause of death in a case-mix adjustment model (
P
trend < 0.05). Adjustment for ultrafiltration rate (UFR) slightly attenuated the association between low renal CL
urea and high cause-specific mortality, whereas adjustment for highest potassium did not have substantial effect. Among 12,169 patients with data on change in RKF, a 6-month decline in renal CL
urea showed graded associations with SCD, non-SCD CVD, and non-CVD risk, whereas the graded associations between faster 6-month decline in urine output and higher death risk were clear only for SCD and non-CVD.
CONCLUSION: Lower RKF and loss of RKF were associated with higher cause-specific mortality among patients initiating thrice-weekly in-center hemodialysis.
AB - INTRODUCTION: The survival benefit of residual kidney function (RKF) in patients on hemodialysis is presumably due to enhanced fluid management and solute clearance. However, data are lacking on the association of renal urea clearance (CL
urea) with specific causes of death.
METHODS: We conducted a longitudinal cohort study of 39,623 adults initiating thrice-weekly in-center hemodialysis from 2007 to 2011 and had data on renal CL
urea and urine volume. Multivariable cause-specific proportional hazards model was used to examine the associations between baseline RKF and cause-specific mortality, including sudden cardiac death (SCD), non-SCD cardiovascular death (CVD), and non-CVD. Restricted cubic splines were fitted for change in RKF over 6 months after initiating hemodialysis.
RESULTS: Among 39,623 patients with data on baseline renal CL
urea and urine volume, there was a significant trend toward a higher mortality risk across lower RKF levels, irrespective of cause of death in a case-mix adjustment model (
P
trend < 0.05). Adjustment for ultrafiltration rate (UFR) slightly attenuated the association between low renal CL
urea and high cause-specific mortality, whereas adjustment for highest potassium did not have substantial effect. Among 12,169 patients with data on change in RKF, a 6-month decline in renal CL
urea showed graded associations with SCD, non-SCD CVD, and non-CVD risk, whereas the graded associations between faster 6-month decline in urine output and higher death risk were clear only for SCD and non-CVD.
CONCLUSION: Lower RKF and loss of RKF were associated with higher cause-specific mortality among patients initiating thrice-weekly in-center hemodialysis.
KW - hemodialysis
KW - non-cardiovascular death
KW - renal urea clearance
KW - residual kidney function
KW - sudden cardiac death
KW - ultrafiltration rate
UR - http://www.scopus.com/inward/record.url?scp=85169792743&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85169792743&partnerID=8YFLogxK
U2 - 10.1016/j.ekir.2023.07.020
DO - 10.1016/j.ekir.2023.07.020
M3 - Article
C2 - 37849997
AN - SCOPUS:85169792743
SN - 2468-0249
VL - 8
SP - 1989
EP - 2000
JO - Kidney International Reports
JF - Kidney International Reports
IS - 10
ER -